Services

Practice Areas

What we do, from the first disclosure conversation to the annuity payments twenty years later.

We draft the specification ourselves, starting from the physics rather than from a template. That usually means several rounds with the inventor before a word of claim language is written: what the invention actually is, which parts are essential, where a competitor would try to design around it. The result is a specification that supports a broad independent claim and a ladder of fallback positions that survive amendment.

With registered US Patent Agents, the firm represents clients directly before the United States Patent and Trademark Office. There is no US associate in the middle adding a markup to every filing, every office action response and every interview. Independent measurement of that prosecution work puts the firm at #96 of 1,024 firms worldwide.

European practice is unforgiving about added matter: what is not in the application as filed generally cannot be added later. We draft with that constraint from the start, so the same specification can be prosecuted in Europe without the expensive rewriting that follows a US-only draft. This covers direct EP filings, responses to the extended European search report (EESR), examination and oral proceedings preparation.

Filing and prosecution before the Israel Patent Office, including applications that begin life in Israel and applications entering the national phase. Useful where the invention is manufactured or first commercialised locally, and often the least expensive way to hold a defensible position while international decisions are still open.

A PCT application keeps most of the world open for a further eighteen months and produces an international search report that tells you a great deal about the likely outcome before the expensive decisions. We file PCT applications, read the report with you, and enter national phase, commonly the US, Europe, China, Korea, Japan and Israel, but also in other jurisdictions. A few countries, Taiwan among them, are not part of the PCT treaty and need a filing within one year of priority.

Most applications are rejected at least once; the question is how the response is built. We treat each office action as a claim-scope decision rather than an obstacle to clear: what the examiner has actually established, what the prior art genuinely teaches, what can be argued without narrowing, and what amendment costs in enforceable scope. Fewer office actions to allowance means lower total fees.

US practice imposes a continuing duty of candour. We maintain the IDS across the life of each application, filing references as they arise, whether from search reports, from related family members or from third-party observations, within the timing windows that keep the case free of avoidable fee and enforceability problems.

Handling the closing stage: reviewing the notice of allowance and the examiner's reasons, checking the claims as allowed against the record, deciding whether a continuation is worth filing before the door closes, paying the issue fee, and confirming the granted text.

Granted patents lapse for one reason more than any other: a missed payment. We docket and manage renewal and maintenance fees across jurisdictions, with reminders early enough that a lapse is a decision rather than an accident.

Before you commit engineering budget to a direction, it is worth knowing what is already patented in it. We run prior-art and freedom-to-operate analysis and report in plain terms: what is blocked, what is arguably clear, where the risk is real and where it is theoretical.

For companies with more than a handful of families: a single docket across all jurisdictions, family maps, deadline management, and periodic review of which families still earn their maintenance cost. IP spend is easier to defend to a board when the portfolio can be seen whole.

What's Next?

Are you ready to take the next step? If so, reach out to us today. One of our experienced patent professionals will be in touch shortly.

Contact us